Pharmaceutical Wholesaler throughout New Zealand. Branches in Auckland, Whangarei, Hamilton, Palmerston North, Wellington, Nelson, Christchurch and Dunedin. We are part of the large health company Ebos which is owned by New Zealanders. Their head office is in Christchurch. Other companies in this group are HCL,( Healthcare Logistics) and One Link. These are both Auckland based companies and service both pharamcy and hospitals throughout NZ.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

OPTIMIZERX ACQUIRES EVINCEMED, A SPECIALTY DRUG PRESCRIPTION INITIATION PLATFORM

OptimizeRx Corporation | March 16, 2022

news image

OptimizeRx Corp. a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a leader in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform supporting pharma manufacturers, hub providers and pharmacies to improve patient access, speed to therapy and activation of af...

Read More

PHARMA TECH

BIOMIND LABS ANNOUNCES DESIGN OF A PHARMACEUTICAL FORM FOR PSYCHEDELIC DRUG DELIVERY USING 3D PRINTING

Biomind Labs | November 25, 2021

news image

Biomind Labs Inc. a leading biotech company in fast-acting psychedelics is pleased to announce the successful design of an oromucosal solid pharmaceutical form obtained by 3D printing using selective laser sintering. The form contains as its active ingredients certain psychedelic molecules that the Company has in its portfolio of psychedelic candidates. This pharmaceutical form is aimed at alleviating neurological and psychiatric disorders, and acting as an anti-inflammatory agent for various in...

Read More

PHARMA TECH

OVERLAND PHARMACEUTICALS PARTNERS WITH ARISGLOBAL TO ACCELERATE SAFETY CAPABILITIES

ArisGlobal | December 08, 2021

news image

ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere® announced its partnership with Overland Pharmaceuticals. Overland, a premier biopharmaceutical company bringing innovative medicines to underserved patients in Asia and worldwide, selected ArisGlobal's LifeSphere Multivigilance program to centralize pharmacovigilance activities and further develop and commercialize advances i...

Read More

CANCER PREVENTION PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION TO THE FDA FOR CPP-1X/SUL FOR TREATMENT OF FAMILIAL ADENOMATOUS POLYPOSIS

Cancer Prevention Pharmaceuticals, CPP-1X/sul | June 29, 2020

news image

Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for CPP-1X/sul for treatment of adults with familial adenomatous polyposis (FAP). FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearly 100% of patients. The clinical...

Read More
news image

BUSINESS INSIGHTS

OPTIMIZERX ACQUIRES EVINCEMED, A SPECIALTY DRUG PRESCRIPTION INITIATION PLATFORM

OptimizeRx Corporation | March 16, 2022

OptimizeRx Corp. a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a leader in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform supporting pharma manufacturers, hub providers and pharmacies to improve patient access, speed to therapy and activation of af...

Read More
news image

PHARMA TECH

BIOMIND LABS ANNOUNCES DESIGN OF A PHARMACEUTICAL FORM FOR PSYCHEDELIC DRUG DELIVERY USING 3D PRINTING

Biomind Labs | November 25, 2021

Biomind Labs Inc. a leading biotech company in fast-acting psychedelics is pleased to announce the successful design of an oromucosal solid pharmaceutical form obtained by 3D printing using selective laser sintering. The form contains as its active ingredients certain psychedelic molecules that the Company has in its portfolio of psychedelic candidates. This pharmaceutical form is aimed at alleviating neurological and psychiatric disorders, and acting as an anti-inflammatory agent for various in...

Read More
news image

PHARMA TECH

OVERLAND PHARMACEUTICALS PARTNERS WITH ARISGLOBAL TO ACCELERATE SAFETY CAPABILITIES

ArisGlobal | December 08, 2021

ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphere® announced its partnership with Overland Pharmaceuticals. Overland, a premier biopharmaceutical company bringing innovative medicines to underserved patients in Asia and worldwide, selected ArisGlobal's LifeSphere Multivigilance program to centralize pharmacovigilance activities and further develop and commercialize advances i...

Read More
news image

CANCER PREVENTION PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION TO THE FDA FOR CPP-1X/SUL FOR TREATMENT OF FAMILIAL ADENOMATOUS POLYPOSIS

Cancer Prevention Pharmaceuticals, CPP-1X/sul | June 29, 2020

Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for CPP-1X/sul for treatment of adults with familial adenomatous polyposis (FAP). FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearly 100% of patients. The clinical...

Read More